NCT00373191View on ClinicalTrials.gov

Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

February 28, 2009

Study Completion Date

December 31, 2013

Conditions
Breast Cancer
Interventions
DRUG

chemotherapy

N/A- not dictated by study

DRUG

endocrine therapy

N/A- not dictated by study

GENETIC

DNA methylation analysis

laboratory analysis

GENETIC

protein analysis

laboratory analysis

OTHER

laboratory biomarker analysis

laboratory analysis

OTHER

questionnaire administration

questionnaire

PROCEDURE

adjuvant therapy

N/A- not dictated by study

PROCEDURE

conventional surgery

N/A- not dictated by study

RADIATION

radiation therapy

N/A- not dictated by study

Trial Locations (1)

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00373191 - Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery | Biotech Hunter | Biotech Hunter